Get started
Author

Emil Barner Dalgaard

Observed names: Dalgaard, Emil, Dalgaard, Emil Barner, E. Barner Dalgaard, EB Dalgaard, Emil B Dalgaard, Emil B. Dalgaard
ORCID: 0009-0000-9656-7084
Observed ORCID: 0009-0000-9656-7084
OpenAlex ID: A5110590099
To switch or not to switch: results of a nationwide guideline of mandatory switching from originator to biosimilar etanercept. One-year treatment outcomes in 2061 patients with inflammatory arthritis from the DANBIO registry
2018 · Bente Glintborg, Anne Gitte Loft, et al. · Annals of the Rheumatic Diseases · 152
PDF
Molecular markers of skeletal muscle hypertrophy following 10 wk of resistance training in oral contraceptive users and nonusers
2020 · Mikkel Oxfeldt, Line Barner Dalgaard, et al. · Journal of Applied Physiology · 32
Influence of Second Generation Oral Contraceptive Use on Adaptations to Resistance Training in Young Untrained Women
2020 · Line B. Dalgaard, Emil B. Jørgensen, et al. · The Journal of Strength and Conditioning Research · 24
FRI0190 Clinical outcomes from a nationwide non-medical switch from originator to biosimilar etanercept in patients with inflammatory arthritis after 5 months follow-up. results from the danbio registry
2017 · B Glintborg, IJ Sørensen, et al. · Annals of the Rheumatic Diseases · 23
PDF
One-Year Clinical Outcomes in 1623 Patients with Inflammatory Arthritis Who Switched from Originator to Biosimilar Etanercept:an Observational Study from the Danish Danbio Registry
2017 · Glintborg, Bente, Omerovic, Emina, et al. · University of Southern Denmark Research Portal (University of Southern Denmark) · 15
The effect of prednisolone initiation and short-term discontinuation on the clinical assessment of polymyalgia rheumatica
2025 · Christoffer S Våben, Andreas W Nielsen, et al. · Rheumatology · 6
Response to: ‘Mandatory, cost-driven switching from originator etanercept to its biosimilar SB4: possible fallout on non-medical switching’ by Cantini and Benucci
2018 · Bente Glintborg, Anne Gitte Loft, et al. · Annals of the Rheumatic Diseases · 4
Response to ''To switch or not to switch': the missing piece in the puzzle of biosimilar literature?' by Scherlinger et al
2020 · Bente Glintborg, Anne Gitte Loft, et al. · Annals of the Rheumatic Diseases · 1
PDF
Pos0160 Kidney Function and Adverse Events After Methotrexate Initiation in Patients With Rheumatoid Arthritis: a Nationwide Danish Cohort Study
2025 · E. Barner Dalgaard, K. Keller, et al. · Annals of the Rheumatic Diseases
Op0346 Diagnostic Accuracy in Polymyalgia Rheumatica - the Effect of Prednisolone Initiation and Short-term Discontinuation
2025 · C. Våben, A.W. Nielsen, et al. · Annals of the Rheumatic Diseases
A simplified model to understand the targeted disease-modifying anti-inflammatory drugs
2024 · Tue Wenzel Kragstrup, Kristine Jagd Ottosen, et al. · Ugeskrift for Læger
PDF
Works count: 12
Citation count: 257
H-index: 6
I10-index: 5
Year
Topic
Type